MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Reliability of the severity subscale of the Toronto Western Spasmodic Torticollis Rating Scale in a multidisciplinary team

    S. Kassaye, W. de Hertogh, S. de Waele, D. Crosiers, E. Gudina, J. de Pauw (Molenstraat 56, Belgium, Ethiopia)

    Objective: To assess the inter-rater reliability of the severity subscale of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in a multidisciplinary team. Background: The…
  • 2023 International Congress

    Genetics of Parkinson’s Disease in Polish patients with positive family history-preeliminary study.

    L. Milanowski, D. Hoffman-Zacharska, M. Geremek, S. Szlufik, A. Friedman, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our study was to find genetic variants associated with the familial forms of Parkinson’s disease (PD) in Polish population. Background: PD…
  • 2023 International Congress

    Safety and efficacy of P2B001 (low dose combination of extended-release pramipexole and rasagiline) in patients with early Parkinson’s disease: Subgroup analyses from a randomized, controlled trial

    D. Falconer, P. Litman, H. Friedman, S. Oren, C. Fitter-Attas (Alexandria, USA)

    Objective: Evaluate the efficacy and safety of P2B001 for different subgroups of patients with early Parkinson’s disease (PD). Background: P2B001 is an investigational, fixed low-dose,…
  • 2023 International Congress

    Patterns of Parkinson disease mitochondrial brain function indexed by 31P magnetic resonance spectroscopy

    F. Lopez, C. Hess, A. Ray, R. O'Connell, A. O'Shea, L. Kenney, A. Ratajska, G. Alexander, A. Woods, M. Okun, D. Bowers (Gainesville, USA)

    Objective: To examine whether individuals with PD show greater temporal than frontal high energy phosphate metabolism (31P MRS ATP) that is similar or different from…
  • 2023 International Congress

    Clinical and genetic characteristics of a cohort of 20 patients with confirmed biallelic pathogenic SPG7 mutations from the North West of England

    R. Heartshorne, J. Proudfoot-Jones, A. Barakat, M. Bonello (Liverpool, United Kingdom)

    Objective: To identify the prevalence and phenotype of patients with biallelic pathogenic SPG7 mutations Background: Spastic Paraplegia Type 7 (SPG7) is an autosomal recessive disorder…
  • 2023 International Congress

    The Critical Path for Parkinson’s Consortium approach to developing consensus recommendations for neuroimaging biomarkers appropriate for use in Parkinson’s disease drug development

    M. Muller, R. Comley, J. Eberling, H. Kazmi, T. Kustermann, P. Maguire, K. Marek, C. Mcginnity, M. Minchik, C. Parker, L. Passamonti, O. Rousset, D. Russell, C. Salinas, J. Seibyl, S. Sivakumaran, J. Stoessl, A. Strafella, D. Tosun-Turgut, Y. Wang, D. Stephenson, G. Pagano (Tucson, USA)

    Objective: To develop consensus recommendations for neuroimaging biomarkers suitable for use in Parkinson’s disease (PD) drug development. Background: Given the anticipated rise in PD prevalence…
  • 2023 International Congress

    Movement disorders in the setting of dengue infection in a rural medical teaching hospital in Gujarat, India

    D. Desai, S. Desai (Anand, India)

    Objective: To determine the frequency and types of movement disorders in patients with dengue. Background: Dengue fever is a common viral infection presenting with fever,…
  • 2023 International Congress

    Clinical and functional determinants of motor reserve in patients with de novo Parkinson’s disease

    S. Prange, M. Hoenig, H. Theis, E. Metereau, S. Thobois, T. van Eimeren (Cologne, Germany)

    Objective: To determine the clinical determinants and the role of serotonergic innervation on motor reserve in patients with de novo Parkinson's disease. Background: Patients with…
  • 2023 International Congress

    Concealment of Parkinson’s Disease: Prevalence and Impact on Health and Quality of Life

    G. Yogev-Seligmann, B. Naamneh Abuelhija, M. Giveon, M. Meir Kestenbaum, M. Kafri (Haifa, Israel)

    Objective: (1) To explore the proportion and personal characteristics of patients who do not disclose their diagnosis of Parkinson's disease (PD) to their family, and…
  • 2023 International Congress

    Detailed illustration of a Turkish patient with homozygous C19ORF12 mutation

    H. Onder, T. Comoglu, S. Comoglu (Ankara, Turkey)

    Objective: To illustrate a rare Turkish patient with homozygous C19ORF12 mutation and discuss limitations regarding the current terminology and classification. Background: Neurodegeneration with brain iron…
  • « Previous Page
  • 1
  • …
  • 247
  • 248
  • 249
  • 250
  • 251
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25128 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley